Literature DB >> 10648668

Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure.

U Schwarz1, M Buzello, E Ritz, G Stein, G Raabe, G Wiest, G Mall, K Amann.   

Abstract

BACKGROUND: An excessive rate of cardiac death is a well-known feature of renal failure. Coronary heart disease is frequent and the possibility has been raised that the natural history of the coronary plaque is different in uraemic patients. We assessed the morphology of coronary arteries in patients with end-stage renal failure and compared them with coronary arteries of matched non-uraemic control patients.
METHODS: Fifty-four cases were identified at autopsy who met the inclusion criteria: cases, end-stage renal disease (n=27); controls, non-renal patients with coronary artery disease (n=27). At autopsy all three coronary arteries were prepared at corresponding sites for investigations: (i) qualitative analysis (after Stary), (ii) quantitative measurements of intima and media thickness (by planimetry), (iii) immunohistochemical analysis of the coronary plaques and (iv) X-ray diffraction of selected calcified plaques.
RESULTS: Qualitative analysis of the coronary arteries showed significantly more calcified plaques of coronary arteries in patients with end-stage renal failure. Plaques of non-uraemic patients were mostly fibroatheromatous. Media thickness of coronary arteries was significantly higher in uraemic patients (187+/-53 microm vs 135+/-29 microm in controls) and intima thickness tended to be higher (158+/-38 microm vs 142+/-31 microm) but this difference was not statistically significant. Plaque area (4.09+/-1. 50 mm(2) vs 4.39+/-0.88 mm(2)) was comparable in both groups. Lumen area, however, was significantly lower in end-stage renal patients. Immunohistochemical analysis of the cellular infiltrate in coronary arteries showed no major differences in these advanced plaques of uraemic and non-uraemic subjects.
CONCLUSION: Coronary plaques in patients with end-stage renal failure are characterized by increased media thickness and marked calcification. In contrast to the previous opinion the most marked difference compared to non-uraemic controls does not concern the size, but the composition of the plaque. Deposition of calcium within the plaques may contribute to the high complication rate in uraemic patients.

Entities:  

Mesh:

Year:  2000        PMID: 10648668     DOI: 10.1093/ndt/15.2.218

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  106 in total

Review 1.  Electron beam tomography as an endpoint for clinical trials of antiatherosclerotic therapy.

Authors:  P Raggi
Journal:  Curr Atheroscler Rep       Date:  2000-07       Impact factor: 5.113

Review 2.  Cardiovascular complications of renal disease.

Authors:  A G Jardine; K McLaughlin
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

Review 3.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

Review 4.  Hyperphosphataemia in renal failure: causes, consequences and current management.

Authors:  Fouad Albaaj; Alastair Hutchison
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 5.  Calciphylaxis and vascular calcification: a continuum of extra-skeletal osteogenesis.

Authors:  Sharon M Moe; Neal X Chen
Journal:  Pediatr Nephrol       Date:  2003-10       Impact factor: 3.714

6.  Impact of non-invasive cardiovascular screening programs as a predictor of cardiovascular events among asymptomatic chronic kidney disease patients.

Authors:  Akihiro Sawai; Yoshinari Yasuda; Susumu Suzuki; Hideki Ishii; Motomitsu Goto; Sawako Kato; Mutsuharu Hayashi; Shoichi Maruyama; Toyoaki Murohara; Yutaka Oiso; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2015-09-24       Impact factor: 2.801

Review 7.  Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Authors:  Nikolaus Marx; Heidi Noels; Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-05-04       Impact factor: 5.460

Review 8.  Coronary revascularization in end-stage renal disease.

Authors:  Khaled M Ziada
Journal:  Curr Cardiol Rep       Date:  2007-09       Impact factor: 2.931

9.  p-Cresyl sulfate promotes the formation of atherosclerotic lesions and induces plaque instability by targeting vascular smooth muscle cells.

Authors:  Hui Han; Yanjia Chen; Zhengbin Zhu; Xiuxiu Su; Jingwei Ni; Run Du; Ruiyan Zhang; Wei Jin
Journal:  Front Med       Date:  2016-09-07       Impact factor: 4.592

Review 10.  The emerging role of phosphate in vascular calcification.

Authors:  Cecilia M Giachelli
Journal:  Kidney Int       Date:  2009-01-14       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.